Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
Based on antitumor activity of statin, we designed a phase III study of capecitabine/CDDP
chemotherapy plus a low-dose simvastatin that is equivalent to cardiovascular dose in
advanced gastric cancer patients.